[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355258-105":59,"doc-detail-355258-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","clinicopathologic-characteristics-and-survival-outcomes-of-patients-with-high-grade-neuroendocrine-cervical-cancer","Clinicopathologic characteristics and survival outcomes of patients with high-grade neuroendocrine cervical cancer","","Observational retrospective study evaluating clinicopathologic features and survival outcomes in a consecutive single-center cohort of high-grade neuroendocrine cervical cancer. Clinical records of cervical cancer patients treated between 2010 and 2023 were reviewed; 54 of 5782 cases (0.93%) met criteria. Patients more often presented before age 40 than other histologic subtypes. Stage-specific 5-year PFS and OS were markedly worse in advanced stages. Multivariate Cox models showed lymph node involvement independently predicted significantly worse PFS and OS.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinicopathologic-characteristics-and-survival-outcomes-of-patients-with-high-grade-neuroendocrine-cervical-cancer/355258/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinicopathologic-characteristics-and-survival-outcomes-of-patients-with-high-grade-neuroendocrine-cervical-cancer/355258.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"Which factor was associated with worse progression-free and overall survival?","Question",{"text":112,"@type":113},"Multivariate analysis indicated that lymph node involvement significantly predicted worse PFS and OS, with adjusted hazard ratios of 7.26 for PFS and 7.98 for OS.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},355258,1790182240,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":131,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":132,"faqs":133,"seo_title":134,"seo_description":67,"update_tm":135,"read_time":136,"preview_page_count":19,"preview_urls":137},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","®  \n Observational Study   \nClinicopathologic characteristics and survival outcomes of patients with high-grade neuroendocrine cervical cancer  \nXinyi Chen, MD, PhDa ,* , Xingzheng Zheng, MDa , Ziguo Yang, MD, PhDb , Feng Sui, MDa , Chao Han, MDa , Chang Lu, MDa , Xiaodan Wang, MDa , Weimin Kong, MD, PhDa  \n\n| Abstract\u003Cbr>This study aims to evaluate the clinicopathologic characteristics and survival of patients with high-grade neuroendocrine cervical cancer in a consecutive cohort from a single center. We retrospectively reviewed clinical data of cervical cancer patients admitted to our hospital between 2010 and 2023. The clinicopathologic and immunohistochemical features and treatment outcomes were summarized. Progression-free survival (PFS) and overall survival (OS) were estimated using a Cox proportional hazards regression model. A total of 5782 patients with cervical cancer were treated in our hospital; 54 (0 .93%) of these patients were diagnosed with high-grade neuroendocrine carcinoma. Compared with patients with other histological subtypes, patients with high-grade neuroendocrine cervical cancer were significantly more likely to be diagnosed before 40 years of age (P = .043) . The 5-year PFS rate was 65.6%(95% confidence interval [CI]: 55.4–75.8%) for stage I disease, dropping markedly to 19.3%(95% CI: 7.9–30.7%) for stages II–III. Similarly, the 5-year OS rate was 69.0%(95% CI: 59.0–79.0%) for stage I, compared with 23.9%(95% CI: 10.0–37.8%) for stages II–IV. According to multivariate analyses, patients with lymph node involvement exhibited significantly worse PFS (adjusted hazard ratio = 7.26; 95% CI: 1.62–32.61; P \u003C .01) and OS (adjusted hazard ratio = 7.98; 95% CI: 1.82–34.87; P \u003C .01) than patients without lymph node involvement. High-grade neuroendocrine cervical carcinoma is a rare and aggressive malignancy whose prognosis is critically dependent on the International Federation of Gynecology and Obstetrics stage. Early diagnosis, achievable through regular human papillomavirus screening followed by systematic colposcopy and biopsy, is important. Furthermore, comprehensive molecular profiling of mutations and the transcriptome is essential to inform personalized management strategies. |\n| --- |\n| Abbreviations: CI = confidence interval , HPV = human papillomavirus, HR = hazard ratio, OS = overall survival, PD-1 = programmed cell death protein 1, PD-L1 = programmed cell death-ligand 1, PFS = progression-free survival. |\n| Keywords: cervical cancer, clinicopathologic characteristics, high-grade neuroendocrine carcinoma, survival |\n\n1. Introduction  \nAlthough human papillomavirus (HPV) vaccination and cervical cancer screening have been widely applied, cervical cancer remains the most prevalent gynecological cancer and a leading cause of mortality and morbidity in women. [1] High-grade neuroendocrine carcinoma of the cervix is a rare and highly aggressive malignancy that accounts for only 0.5 − 1.0% of all cervical cancers. [2] Compared with patients with squamous cell carcinoma or adenocarcinoma, the most common histologic type of cervical carcinoma, patients diagnosed with high-grade  \nneuroendocrine cervical cancer are more likely to have lymph node invasion and an unfavorable prognosis. [3] Despite advancesin cancer therapy over the past 3 decades, overall survival (OS) in patients with high-grade neuroendocrine cervical cancer has not improved. [3,4]  \nCurrently, there is no consensus on the best strategies for the prevention, screening, diagnosis, and treatment of high-grade neuroendocrine cervical cancer. An analysis of detailed clinical information of patients is needed to better understand the clinical characteristics and risk factors for this type of cancer. In this study, we retrospectively summarized the clinical data  \nXC, XZ, and ZY contributed to this article equally.  \nThis study was supported by Supported by Beijing Obstetrics and Gynecology Hospital, Capital Medical University (FCYYJC202501) and Be","cbCaiefFeD1MBXVu","https://ap.wps.com/l/cbCaiefFeD1MBXVu","pdf",785721,"English","# Abstract\n# Introduction\n# Patients and methods\n## Patients","[{\"question\":\"Which factor was associated with worse progression-free and overall survival?\",\"answer\":\"Multivariate analysis indicated that lymph node involvement significantly predicted worse PFS and OS, with adjusted hazard ratios of 7.26 for PFS and 7.98 for OS.\"}]","Clinicopathologic characteristics and survival outcomes of patients with high-grade neuroendocrine cervical cancer | PDF",1790117209,18,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a9ced80f35ad93cd455e0eb0454b423.webp",983,1310,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c19c22d8091a239df559f30a5a42c33.webp",982,1309,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a371793c528f724d6af11ae064a6bf3.webp",981,1308,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7624799f625732adffdbb8fb99ca5b00.webp",980,1306]